IMUNON INC. - COMMON STOCK
0.9577
24-一月-25 15:45:00
15 分钟延时
股票
+0.0002
+0.02%
今日范围
0.9359 - 1.0200
ISIN
N/A
来源
NASDAQ
-
IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update
13 5月 2024 07:00:01 条件 Nasdaq GlobeNewswire
-
IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
08 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
06 5月 2024 10:00:00 条件 Nasdaq GlobeNewswire
-
IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101
18 4月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
IMUNON Reports Compliance with Nasdaq Listing Requirements
11 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
IMUNON Reports 2023 Financial Results and Provides Business Update
28 3月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
IMUNON Receives $1.3 Million from Sale of its New Jersey Net Operating Losses
25 3月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
21 3月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
IMUNON Files IND Application to Begin Human Testing of IMNN-101
13 3月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
IMUNON Announces Leadership Change
12 3月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
29 2月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
27 2月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
IMNN-101 Preclinical Data in SARS CoV-2 Published in Peer-Reviewed Journal Vaccine
22 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
11 12月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
IMUNON’s VP of R&D to Present at the Vaccines Summit-2023
14 11月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
IMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Update
14 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
07 11月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
IMUNON’s Chief Science Officer to Present at the 3rd International Vaccines Congress
23 10月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
19 10月 2023 07:30:00 条件 Nasdaq GlobeNewswire
-
18 10月 2023 07:30:00 条件 Nasdaq GlobeNewswire